Skip to main content
. 2018 Aug 22;41(11):zsy158. doi: 10.1093/sleep/zsy158

Table 4.

Odds ratios (95% CIs) for the associations of sleep duration (n = 1927) and insomnia symptoms (n = 1988) at Exam 5 with changes in aMed score between Exam 1 and Exam 5

Changes in the aMed Score from Exam 1 to Exam 5 Sleep duration
(reference: <6 hr/night)
Insomnia symptoms
(reference: no insomnia)
6 to <7 hr/night
n = 614
7–8 hr/night
n = 516
>8 hr/night
n = 219
Insomnia
n = 711
No change vs. decrease in score
 Model 1 1.05 (0.77, 1.45) 1.11 (0.79, 1.54) 1.08 (0.71, 1.65) 0.64 (0.49, 0.83)***
 Model 2 1.07 (0.78, 1.47) 1.10 (0.79, 1.54) 1.09 (0.71, 1.68) 0.64 (0.49, 0.83)***
 Model 3 1.04 (0.74, 1.45) 1.13 (0.80, 1.60) 1.13 (0.72, 1.80) 0.65 (0.50, 0.85)**
 Model 4 0.98 (0.68, 1.40) 1.06 (0.73, 1.55) 0.96 (0.57, 1.61) 0.61 (0.45, 0.82)**
Increase vs. decrease in score
 Model 1 1.35 (1.04, 1.75)* 1.30 (0.98, 1.71) 1.04 (0.72, 1.50) 0.90 (0.73, 1.11)
 Model 2 1.36 (1.05, 1.76)* 1.29 (0.98, 1.71) 1.04 (0.72, 1.50) 0.90 (0.73, 1.11)
 Model 3 1.30 (0.99, 1.71) 1.26 (0.94, 1.69) 1.18 (0.80, 1.75) 0.90 (0.72, 1.12)
 Model 4 1.34 (0.99, 1.80) 1.30 (0.95, 1.79) 1.15 (0.74, 1.77) 0.92 (0.72, 1.17)

For sleep duration (ref <6 hr, n = 578).

For insomnia symptoms (ref no insomnia symptoms, n = 1277).

MODEL 1: adjusted for age, gender, race/ethnicity.

MODEL 2: adjusted for covariates in Model 1 as well as education.

MODEL 3: adjusted for covariates in Model 2 as well as cigarette smoking, intentional exercise and total energy intake (Kcal/day).

MODEL 4: adjusted for covariates in Model 3 as well as body mass index (Kg/m2), hypertension, diabetes, depressive symptoms (CESD score ≥ 16), AHI (continuous), antidepressants, and antipsychotic medication, plus insomnia symptoms when main outcome was sleep duration and sleep duration when main outcome was insomnia symptoms

*p < 0.05; **p ≤ 0.01; ***p ≤ 0.001. Bold values indicate significance.